When it comes to diagnosing and treating the novel coronavirus, sooner is better.
Healthcare providers need to diagnose COVID-19 accurately and quickly to improve patient outcomes and reduce the risk of viral exposure. Unfortunately, PCR nasal swab testing can take days to get a result, leaving individuals and communities potentially vulnerable to the virus. PCR nasal swabs also produce a high rate of false negatives.
In contrast, chest computed tomography (CT) has a high sensitivity, making it preferable in accurately identifying and diagnosing suspected COVID-19 patients.
The new NovaradAI COVID-19 module combines the accuracy of chest CT with the analytical power of artificial intelligence (AI) to identify patients with COVID-19.
This feature works in seconds, reducing exposure risk for clinicians, staff, and other patients. Providers can then act quickly to treat and isolate infected patients.
This module is supported by Azure, Microsoft’s powerful cloud computing service. No protected health information is stored in Azure, so the COVID-19 AI Diagnostic Assistant is fully HIPAA and HITECH compliant.
The module’s accurate, comprehensive report includes:
Our Diagnostic Assistant is now free to use around the world. You can download the NovaradAI COVID-19 AI Diagnostic Assistant at www.novarad.net/covidai. (We're excited about the "free" part.)